Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Women’s Health Initiative (WHI) - Life and Longevity After Cancer (LILAC)(WHI-LILAC-BioLINCC)

ABSTRACT: Women’s Health Initiative (WHI) - Life and Longevity After Cancer (LILAC)(WHI-LILAC-BioLINCC)

PROVIDER: PRJNA1291287 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Women’s Health Initiative (WHI) - Life and Longevity After Cancer (LILAC)(WHI-LILAC-BioLINCC)

Project description:Women’s Health Initiative (WHI) - Life and Longevity After Cancer (LILAC)(WHI-LILAC-BioLINCC)

| PRJNA1291286 | ENA

WHI Cohort

Project description:WHI Cohort

| PRJNA76021 | ENA

Center for Common Disease Genomics [CCDG] - Cardiovascular: Women's Health Initiative (WHI) Cohort

Project description:Center for Common Disease Genomics [CCDG] - Cardiovascular: Women's Health Initiative (WHI) Cohort

| PRJNA955371 | ENA

Center for Common Disease Genomics [CCDG] - Cardiovascular: Women's Health Initiative (WHI) Cohort

Project description:Center for Common Disease Genomics [CCDG] - Cardiovascular: Women's Health Initiative (WHI) Cohort

| PRJNA955372 | ENA

NHLBI TOPMed: Women's Health Initiative (WHI)

Project description:<p>This is Whole Genome Sequencing data from the TOPMed participation of the Women's Health Initiative. Approximately 11,100 subjects were involved in this study: approximately 1,100 cases of VTE, 4,000 cases of ischemic stroke, 900 cases of hemorrhagic stroke, and 5,100 controls. Summary level phenotypes for the WHI Cohort study participants can be viewed at the top-level study page phs000200 WHI Cohort. Individual level phenotype data and molecular data for all WHI top-level study and substudies are available by requesting Authorized Access to the WHI Cohort study <a href="./study.cgi?study_id=phs000200">phs000200</a>.</p>

| phs001237 | dbGaP

Homo sapiens

Project description:Women's Health Initiative (WHI)

| PRJNA312995 | ENA

The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) Study: Description and Baseline Characteristics of Participants.

Project description:Background: The Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) study offers an important opportunity to advance cancer research by extending the original WHI studies to examine survivorship in women diagnosed with cancer during their participation in WHI.Methods: The goals of LILAC are to (i) obtain cancer treatment information and long-term cancer outcomes for women diagnosed with one of eight selected cancers (breast, endometrial, ovarian, lung, and colorectal cancers, and melanoma, lymphoma, and leukemia); (ii) augment the existing WHI biorepository with fixed tumor tissue from the solid tumor sites for cancers diagnosed since 2002; and (iii) develop, refine, and validate methods to use administrative data to capture treatment and recurrence data. Methods for accomplishing these goals are described, as are results from the initial LILAC participant survey.Results: A total of 9,934 WHI participants living with cancer were eligible for LILAC participation, of which 78% (N = 7,760) agreed to participate. Among the three most prevalent cancer types, 54% are breast cancer survivors, 11% are melanoma survivors, and 10% are survivors of colorectal cancer.Conclusions: In addition to describing this resource, we present pertinent lessons that may assist other investigators interested in embedding survivorship research into existing large epidemiologic cohorts.Impact: The LILAC resource offers a valuable opportunity for researchers to study cancer survivorship and issues pertinent to cancer survivors in future studies. Cancer Epidemiol Biomarkers Prev; 27(2); 125-37. ©2017 AACR.

| S-EPMC5809310 | biostudies-literature

Homo sapiens

Project description:Women’s Health Initiative Sight Exam (WHISE)

| PRJNA257233 | ENA

i5k initiative

Project description:i5k initiative

| PRJNA163993 | ENA

DREAM, a Possible Answer to the Estrogen Paradox of the Women’s Health Initiative Trial

Project description:DREAM, a Possible Answer to the Estrogen Paradox of the Women’s Health Initiative Trial

| PRJNA586892 | ENA